Omnicell, Inc. (NASDAQ: OMCL) announces results for its fiscal year and fourth quarter ended December 31, 2018.
Company Also Sweeps Category Leader Designations for Central Pharmacy Automation Hardware
Latest Automated Solutions Help Enhance Quality and Safety for Medication Management and In-house Sterile Compounding in Pharmacy and Patient Care Areas
New Technologies Target Zero Error, Fully Automated Medication Management
Automated Solutions Help Enhance Quality and Safety for Medication Management and In-house Sterile Compounding
Technology Evolution Affirms Omnicell’s Mission to Enable Pharmacists to Perform at the Top of their License
Omnicell, Inc. (NASDAQ: OMCL) announces results for its third quarter ended September 30, 2018.
Solutions Leverage Automation to Help Optimize Hospital Workflows, Improve Financial Performance and Enhance Patient Safety
Hospital Selects Combined Solution for End-to-End Compliance and Workflow
Unified Platform for Clinical and Workflow Interventions Designed to Help Retail Pharmacies Improve Outcomes and Grow Business
Company Hosts Reception at AHRMM Booth Exploring How Technology Helps to Increase Safety and Efficiency, While Lowering Costs
New Technology and Interoperability with Hospital's EHR Enhances Medication Inventory Visibility, Patient Safety
Omnicell, Inc. (NASDAQ: OMCL) announces results for its second quarter ended June 30, 2018.
Collaboratively Developed Technologies Support Patient-Centric Care By Allowing Nurses to Spend More Time at the Bedside
Automated Solutions Help Improve Medication Safety for Mental Health Patients Across the U.S. and its Territories
Results from Dr. Sharrel Pinto of the University of Toledo Published in Innovations in Pharmacy